KR102797129B1 - 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물 - Google Patents

테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물 Download PDF

Info

Publication number
KR102797129B1
KR102797129B1 KR1020217016041A KR20217016041A KR102797129B1 KR 102797129 B1 KR102797129 B1 KR 102797129B1 KR 1020217016041 A KR1020217016041 A KR 1020217016041A KR 20217016041 A KR20217016041 A KR 20217016041A KR 102797129 B1 KR102797129 B1 KR 102797129B1
Authority
KR
South Korea
Prior art keywords
compound
fluoro
pharmaceutically acceptable
acceptable salt
hcm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217016041A
Other languages
English (en)
Korean (ko)
Other versions
KR20210086673A (ko
Inventor
마크 그릴로
브라이언 케인
조한 오슬로브
민 종
파비엥 톰슨
Original Assignee
미요카디아, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미요카디아, 인크. filed Critical 미요카디아, 인크.
Priority to KR1020257012076A priority Critical patent/KR20250053228A/ko
Publication of KR20210086673A publication Critical patent/KR20210086673A/ko
Application granted granted Critical
Publication of KR102797129B1 publication Critical patent/KR102797129B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hospice & Palliative Care (AREA)
KR1020217016041A 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물 Active KR102797129B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020257012076A KR20250053228A (ko) 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862752278P 2018-10-29 2018-10-29
US62/752,278 2018-10-29
PCT/US2019/058297 WO2020092208A1 (en) 2018-10-29 2019-10-28 Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020257012076A Division KR20250053228A (ko) 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물

Publications (2)

Publication Number Publication Date
KR20210086673A KR20210086673A (ko) 2021-07-08
KR102797129B1 true KR102797129B1 (ko) 2025-04-18

Family

ID=68841171

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020217016041A Active KR102797129B1 (ko) 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물
KR1020257012076A Pending KR20250053228A (ko) 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020257012076A Pending KR20250053228A (ko) 2018-10-29 2019-10-28 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물

Country Status (29)

Country Link
US (5) US11034693B2 (https=)
EP (3) EP4736855A2 (https=)
JP (3) JP7447110B2 (https=)
KR (2) KR102797129B1 (https=)
CN (3) CN113056465B (https=)
AR (1) AR116880A1 (https=)
AU (2) AU2019373206B2 (https=)
BR (1) BR112021008077A2 (https=)
CA (1) CA3118293A1 (https=)
CL (1) CL2021001083A1 (https=)
CO (1) CO2021005540A2 (https=)
DK (2) DK3873904T3 (https=)
EA (1) EA202191152A1 (https=)
ES (1) ES2986923T3 (https=)
FI (2) FI3873904T3 (https=)
HR (2) HRP20241065T1 (https=)
HU (1) HUE068265T2 (https=)
IL (2) IL325304A (https=)
LT (2) LT3873904T (https=)
MX (2) MX2021004955A (https=)
PE (1) PE20211780A1 (https=)
PL (1) PL3873904T3 (https=)
PT (1) PT3873904T (https=)
RS (1) RS65963B1 (https=)
SG (1) SG11202104218SA (https=)
SI (2) SI3873904T1 (https=)
SM (1) SMT202400358T1 (https=)
TW (3) TW202521537A (https=)
WO (1) WO2020092208A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3088347A1 (en) 2018-01-17 2019-07-25 Glaxosmithkline Intellectual Property Development Limited Pi4kiii.beta. inhibitors
EA202191152A1 (ru) 2018-10-29 2022-01-19 Миокардиа, Инк. Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
MX2023002024A (es) 2020-08-28 2023-05-10 Myokardia Inc Métodos de tratamiento con modulador de miosina.
CN114149423B (zh) * 2020-09-08 2023-12-12 江苏恒瑞医药股份有限公司 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
CN114456163B (zh) * 2020-11-09 2023-08-11 江苏恒瑞医药股份有限公司 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
WO2022105852A1 (zh) 2020-11-20 2022-05-27 江苏恒瑞医药股份有限公司 三嗪二酮类衍生物、其制备方法及其在医药上的应用
CN117083275A (zh) 2021-03-04 2023-11-17 赛特凯恩蒂克公司 心脏肌节抑制剂
CN119053591A (zh) 2022-05-20 2024-11-29 江苏恒瑞医药股份有限公司 一种三嗪二酮类衍生物的晶型及制备方法
IL318417A (en) 2022-07-29 2025-03-01 Myokardia Inc Crystalline forms of (6s,7s)-6-fluoro-7-(2-fluoro-5-methylphenyl)-3-(tetrahydro-2h-pyran-4-yl)-5,6,7,8-tetrahydropyrido[2 ,3-d]pyrimidine-2,4(lh,3h)-dione

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205223A1 (en) 2013-06-21 2014-12-24 MyoKardia, Inc. Pyrimidinedione compounds against cardiac conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU725689B2 (en) 1995-06-07 2000-10-19 G.D. Searle & Co. Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for treatment of congestive heart failure
GB9715892D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
US9663516B2 (en) * 2014-12-18 2017-05-30 MyoKardia, Inc. Bicyclic-pyrimidinedione compounds
EA202191152A1 (ru) 2018-10-29 2022-01-19 Миокардиа, Инк. Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205223A1 (en) 2013-06-21 2014-12-24 MyoKardia, Inc. Pyrimidinedione compounds against cardiac conditions

Also Published As

Publication number Publication date
FI4464321T3 (fi) 2026-03-11
TWI876902B (zh) 2025-03-11
IL282740A (en) 2021-06-30
JP2025138748A (ja) 2025-09-25
JP2024063091A (ja) 2024-05-10
EP4736855A2 (en) 2026-05-06
US11034693B2 (en) 2021-06-15
AU2019373206B2 (en) 2024-11-14
PT3873904T (pt) 2024-10-08
PL3873904T3 (pl) 2024-12-23
ES2986923T3 (es) 2024-11-13
AR116880A1 (es) 2021-06-23
WO2020092208A1 (en) 2020-05-07
TWI837202B (zh) 2024-04-01
KR20210086673A (ko) 2021-07-08
JP7703716B2 (ja) 2025-07-15
CN113056465B (zh) 2025-01-28
SI4464321T1 (sl) 2026-03-31
CN119977963A (zh) 2025-05-13
TW202426449A (zh) 2024-07-01
US20250282779A1 (en) 2025-09-11
SMT202400358T1 (it) 2024-11-15
HUE068265T2 (hu) 2024-12-28
US20240025894A1 (en) 2024-01-25
CO2021005540A2 (es) 2021-07-30
SI3873904T1 (sl) 2024-10-30
RS65963B1 (sr) 2024-10-31
JP7447110B2 (ja) 2024-03-11
DK3873904T3 (da) 2024-08-05
HRP20260161T1 (hr) 2026-03-27
EP4464321A2 (en) 2024-11-20
MX2021004955A (es) 2021-07-21
EP3873904B1 (en) 2024-07-10
AU2019373206A1 (en) 2021-06-17
TW202521537A (zh) 2025-06-01
CN113056465A (zh) 2021-06-29
LT4464321T (lt) 2026-03-25
BR112021008077A2 (pt) 2021-08-03
CN119977962A (zh) 2025-05-13
EA202191152A1 (ru) 2022-01-19
EP3873904A1 (en) 2021-09-08
IL325304A (en) 2026-02-01
HRP20241065T1 (hr) 2024-11-08
EP4464321A3 (en) 2025-01-01
DK4464321T3 (da) 2026-02-09
LT3873904T (lt) 2024-11-11
JP2022506524A (ja) 2022-01-17
EP4464321B1 (en) 2026-01-21
MX2024004892A (es) 2024-05-07
SG11202104218SA (en) 2021-05-28
IL282740B1 (en) 2026-01-01
US20220340569A1 (en) 2022-10-27
US12344607B2 (en) 2025-07-01
CA3118293A1 (en) 2020-05-07
TW202030189A (zh) 2020-08-16
AU2025200975A1 (en) 2025-03-06
CL2021001083A1 (es) 2021-09-24
KR20250053228A (ko) 2025-04-21
US20220106314A1 (en) 2022-04-07
PE20211780A1 (es) 2021-09-08
US20200165247A1 (en) 2020-05-28
FI3873904T3 (fi) 2024-08-09

Similar Documents

Publication Publication Date Title
KR102797129B1 (ko) 테트라히드로피란 (thp)-치환된 비시클릭-피리미딘디온 화합물
US20230158027A1 (en) Methods of treatment with myosin modulator
TWI504599B (zh) 倍米羅樂（ｐｅｍｉｒｏｌａｓｔ）的新結晶形式
HK40119292A (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
EA053114B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
HK40061965B (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
HK40061965A (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
EA050645B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
EA046692B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
WO2009153261A1 (en) HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
TW201028390A (en) Flavononol renin inhibitor compounds and methods of use thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210526

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20221025

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240708

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20250114

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20250414

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250414

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250415

End annual number: 3

Start annual number: 1

PG1601 Publication of registration